HealthEquity Debt to Equity Ratio 2014-2023 | HQY
HealthEquity Debt/Equity Ratio Historical Data | |||
---|---|---|---|
Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
2023-10-31 | $1.11B | $1.99B | 0.56 |
2023-07-31 | $1.12B | $1.95B | 0.57 |
2023-04-30 | $1.12B | $1.92B | 0.58 |
2023-01-31 | $1.19B | $1.90B | 0.63 |
2022-10-31 | $1.18B | $1.88B | 0.63 |
2022-07-31 | $1.21B | $1.87B | 0.65 |
2022-04-30 | $1.21B | $1.86B | 0.65 |
2022-01-31 | $1.26B | $1.85B | 0.68 |
2021-10-31 | $1.23B | $1.87B | 0.66 |
2021-07-31 | $1.29B | $1.86B | 0.69 |
2021-04-30 | $1.31B | $1.85B | 0.71 |
2021-01-31 | $1.33B | $1.38B | 0.97 |
2020-10-31 | $1.30B | $1.36B | 0.96 |
2020-07-31 | $1.32B | $1.34B | 0.99 |
2020-04-30 | $1.52B | $1.04B | 1.46 |
2020-01-31 | $1.54B | $1.03B | 1.49 |
2019-10-31 | $1.54B | $1.02B | 1.52 |
2019-07-31 | $0.08B | $1.02B | 0.08 |
2019-04-30 | $0.07B | $0.53B | 0.13 |
2019-01-31 | $0.03B | $0.48B | 0.07 |
2018-10-31 | $0.02B | $0.46B | 0.05 |
2018-07-31 | $0.02B | $0.43B | 0.05 |
2018-04-30 | $0.02B | $0.40B | 0.05 |
2018-01-31 | $0.02B | $0.35B | 0.07 |
2017-10-31 | $0.02B | $0.33B | 0.07 |
2017-07-31 | $0.02B | $0.32B | 0.05 |
2017-04-30 | $0.01B | $0.29B | 0.04 |
2017-01-31 | $0.02B | $0.26B | 0.07 |
2016-10-31 | $0.01B | $0.25B | 0.05 |
2016-07-31 | $0.01B | $0.24B | 0.05 |
2016-04-30 | $0.01B | $0.22B | 0.04 |
2016-01-31 | $0.02B | $0.20B | 0.08 |
2015-10-31 | $0.01B | $0.20B | 0.07 |
2015-07-31 | $0.01B | $0.19B | 0.06 |
2015-04-30 | $0.01B | $0.16B | 0.07 |
2015-01-31 | $0.02B | $0.14B | 0.10 |
2014-10-31 | $0.01B | $0.14B | 0.09 |
2014-07-31 | $0.06B | $0.01B | 5.16 |
2014-04-30 | $0.00B | $0.00B | 0.00 |
2014-01-31 | $0.00B | 0.00 | |
2013-10-31 | $0.00B | $0.00B | 0.00 |
2013-07-31 | $0.00B | $0.00B | 0.00 |
2013-01-31 | $0.05B | $-0.01B | -8.25 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $6.819B | $1.000B |
HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $120.362B | 15.62 |
Cencora (COR) | United States | $48.434B | 19.33 |
ICON (ICLR) | Ireland | $27.216B | 26.84 |
DiDi Global (DIDIY) | China | $18.072B | 0.00 |
Avantor (AVTR) | United States | $17.215B | 23.72 |
CochLear (CHEOY) | $14.342B | 0.00 | |
Viatris (VTRS) | United States | $13.916B | 3.97 |
Charles River Laboratories (CRL) | United States | $13.617B | 24.92 |
Revvity (RVTY) | United States | $12.775B | 22.24 |
Medpace Holdings (MEDP) | United States | $12.388B | 45.35 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.873B | 0.00 |
Natera (NTRA) | United States | $10.868B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $6.762B | 34.33 |
Bausch + Lomb (BLCO) | Canada | $5.939B | 22.86 |
Doximity (DOCS) | United States | $5.035B | 37.49 |
Organon (OGN) | United States | $4.632B | 4.49 |
Surgery Partners (SGRY) | United States | $3.696B | 34.34 |
Progyny (PGNY) | United States | $3.574B | 59.74 |
Sotera Health (SHC) | United States | $3.261B | 16.01 |
Life Times (LTH) | United States | $2.896B | 32.00 |
GoodRx Holdings (GDRX) | United States | $2.789B | 141.20 |
Premier (PINC) | United States | $2.587B | 9.47 |
Teladoc Health (TDOC) | United States | $2.514B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.341B | 7.57 |
Agilon Health (AGL) | United States | $2.044B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.688B | 0.00 |
NovoCure (NVCR) | Jersey | $1.400B | 0.00 |
Agiliti (AGTI) | United States | $1.383B | 22.60 |
Establishment Labs Holdings (ESTA) | $1.352B | 0.00 | |
Alignment Healthcare (ALHC) | United States | $0.888B | 0.00 |
Pediatrix Medical (MD) | United States | $0.807B | 8.34 |
Embecta (EMBC) | United States | $0.711B | 4.70 |
COMPASS Pathways (CMPS) | United Kingdom | $0.577B | 0.00 |
InnovAge Holding (INNV) | United States | $0.576B | 0.00 |
Enhabit (EHAB) | United States | $0.569B | 51.54 |
Beauty Health (SKIN) | United States | $0.537B | 0.00 |
CareDx (CDNA) | United States | $0.496B | 0.00 |
MultiPlan (MPLN) | United States | $0.487B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.466B | 12.21 |
LifeMD (LFMD) | United States | $0.446B | 0.00 |
DocGo (DCGO) | United States | $0.405B | 64.83 |
ModivCare (MODV) | United States | $0.340B | 4.51 |
Sharecare (SHCR) | United States | $0.305B | 0.00 |
Sera Prognostics (SERA) | United States | $0.298B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.271B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.264B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.228B | 0.00 |
Biodesix (BDSX) | United States | $0.141B | 0.00 |
Oncology Institute (TOI) | United States | $0.125B | 0.00 |
So-Young (SY) | China | $0.107B | 35.67 |
Pono Capital Two (PTWO) | United States | $0.070B | 0.00 |
Nutex Health (NUTX) | United States | $0.069B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
NeueHealth (NEUE) | United States | $0.050B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.041B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.038B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
OncoCyte (OCX) | United States | $0.025B | 0.00 |
BIMI Medical (BIMI) | United States | $0.023B | 0.00 |
DermTech (DMTK) | United States | $0.023B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
TRxADE HEALTH (MEDS) | United States | $0.011B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.011B | 0.00 |
OpGen (OPGN) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.007B | 0.00 |
Assure Holdings (IONM) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
Aclarion (ACON) | United States | $0.001B | 0.00 |